A 60-year-old woman came into our office for her annual examination. We noted that she had lost 1.5 inches in height.
A 60-year-old woman came into our office for her annual examination. We noted that she had lost 1.5 inches in height. We secured an immediate appointment with the dual-energy x-ray absorptiometry (DXA) technician. The result was a T-score of –1.5 (low bone mass, osteopenia). The questions were: How to treat her condition? Was a prescription therapy needed? Which therapy (eg, bisphosphonate, selective estrogen-receptor modular [SERM], or parathyroid hormone [PTH]) was most appropriate? How should she be treated in light of the many complications from long-term therapy?
Eventually, our dilemma would be how to treat this woman without overtreating her. To make an appropriate decision about whether and how to treat her, associated information must be gathered, including history and laboratory results. Evaluation guidelines are followed by discussion of 3 different scenarios.
History
Laboratory workup
These tests should be ordered:
Unraveling preeclampsia: Insights into heterogeneity and intravascular inflammation
April 22nd 2024A recent study delved into the intricate clusters of term preeclampsia, shedding light on its diverse manifestations and the pivotal role of intravascular inflammation, paving the way for improved classification and management strategies.
Read More
Personalized opioid protocol for cesarean deliveries: Reduced prescriptions reported
April 19th 2024A recent suggests that implementing a personalized opioid prescription protocol significantly reduces total morphine milligram equivalents and the number of opioid tablets prescribed at discharge following cesarean delivery.
Read More
Long-term mortality risks for women with adverse pregnancy outcomes
April 19th 2024A recent study revealed that women who experience major adverse pregnancy outcomes face heightened long-term mortality risks, shedding light on the need for comprehensive understanding and preventative measures in women's health.
Read More